
Navneet Majhail: Access barriers to anti-CD19+ CART therapies for lymphoma
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon, shared on LinkedIn:
“Hot off the press! Work from Minoo Battiwalla et al on behalf of HCA Healthcare, Sarah Cannon Cancer. Network that highlights access barriers to CART therapies for lymphoma. Among patients who made it as a referral to a Sarah Cannon Transplant and Cellular Therapy Network CART center between 2018-2022, 40% did not make it to CART infusion. Emphasizes that a lot of work still needs to be done to enhance access to these transformative therapies.”
Authors: Minoo BattiwallaMichael TeesIan FlinnJeremy PantinJesus BerdejaTara GregoryMichael MarisVikas BhushanEstil VanceJohn MathewsCarlos BachierPaul ShaughnessyAravind RamakrishnanShahbaz MalikShahram MoriCasey MartinRocky BillupsBetsy BlunkCharles F. LeMaistreNavneet S. Majhail
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023